Itaconix PLC CEO John Shaw talked with Proactive about the company’s latest financial results and operational progress as it continues its push towards profitability and scale.
Shaw said, “We’re going to be a large specialty ingredient company. 20 million, 40 million, 100 million. Those are our ambitions,” highlighting confidence in the company’s growth prospects through scale inhibitors and odour neutralizers used in high-performing detergents.
He outlined progress against four key goals for 2025, including rebuilding the North American cleaning customer base, expanding in Europe, increasing adoption of odour neutralizers, and launching its biomaterials platform. Shaw confirmed the company has already achieved these, with its SPARX programme set to deliver 10 new products to market by year-end.
He also referenced recent momentum in Europe, new commercial traction through a partnership with Croda, and early demand via e-commerce for its BIOAsterix offering.
On capacity, Shaw said the company is positioned to meet forecast demand through 2026 and is already preparing for 2027, noting that longer-term plans may include new facilities to support larger customer volumes.
Shaw expressed confidence in ending 2025 strongly and expects continued growth into 2026.
Proactive: John, very good to speak with you today. You reported top line results back in July, today you've released all of the details and the results look impressive.
John Shaw: The details show that we have valuable products, that we have great customers making safer, better performing detergents, that we meet our needs for the efficient operation and effective team. And that we are combining these to drive growth and make a dramatic step towards profitability.
Proactive: John, what were the key factors in these results?
John Shaw: We set out four goals earlier this year. One is to rebuild our North American cleaning customer base for better long-term profitability and growth. Two is to expand our adoption scale and division in Europe. Three is the increased traction for our odour neutralizer. And four, we got our biomatrix building blocks business up and running.
We have achieved each of these. Our SPARX program is doing just what we need to get real next-generation products into the right hands. We have over ten relationships at various stages of development across brands and detergent makers. That will turn into ten new products on the market by the end of this year, and already about eight for 2026.
Our EU revenues speak for themselves and have dramatically increased. Our odour neutralisation is getting more attention than we've ever seen, as you can see from our new Croda agreement that we announced a couple of months ago. We launched our BIOAsterix with our first e-commerce efforts and already have some orders. North America, Europe, odour neutralisation, plant-based building blocks—we're hitting it all.
Proactive: John, we're close to the end of the third quarter. How has the second half started? And what are your expectations for the full year?
John Shaw: Well, Stephen, I'm quite sure that we will have a very fun chat when you and I sit down to discuss our trading update in early 2026. We're off to a good start, and we've already hit some new milestones.
Proactive:
And how do you see this momentum leading into 2026?
John Shaw: 2025 is going to end well, and our customers have some nice wins coming online in the first half of 2026. So I think we're going to have a very strong 2026.
Proactive: John, with this much growth, do you have the production capacity to meet customer demand?
John Shaw: I know it's always a big question. We're in excellent shape for our current demand forecast. Our fulfilment team, led by Operations Director John Pelech, completed improvements to our production line and our production team in late spring to meet all of our needs for 2026. They are also close to completing another round of upgrades to meet all of our needs and our current plans for 2027.
Proactive: You recently mentioned long-term plans for production. Can you expand on those, John?
John Shaw: Well, Stephen, we’re going to be a large specialty ingredient company. 20 million, 40 million, 100 million. Those are our ambitions. Because our scale inhibitors and our odour neutralizers are highly valuable in competitive, high-performing detergents.
Our tremendous growth in Europe over the last two years shows the recognition that we're getting from larger detergent producers. That recognition is slowly turning into projects in our customer pipeline for larger and larger potential volumes.
These volumes are probably beyond what we would want to do here in Stratham. So we're starting to see—I'll emphasise, starting—to think about how we might expand to meet possible volumes from the largest producers. So those are within the scope of what we're planning. We need to think three to five years out, and that is judicious on our part, but nothing specific at this time.
Proactive: John, when will you reach profitability?
John Shaw: Well, as you can see from our first half results, one more sizable jump in revenues, and we're there. But that's not enough. Being profitable is not enough. We are going to be a large specialty ingredient company. And we are well on the path to becoming that.
Proactive: Well, John, congratulations on your latest results. Thank you very much for speaking with us today.